<html class="gs_el_sm gs_pfcs"><head><title>‪Paul Loadman‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=7MtgsawAAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Pharmacokinetics and Drug Metabolism, University of Bradford‬ - ‪‪Cited by 5,053‬‬ - ‪Pharmacokinetics‬ - ‪Drug metabolism‬ - ‪Drug delivery‬ - ‪Cancer Pharmacology‬ - ‪Prodrug design‬"><meta property="og:description" content="‪Professor of Pharmacokinetics and Drug Metabolism, University of Bradford‬ - ‪‪Cited by 5,053‬‬ - ‪Pharmacokinetics‬ - ‪Drug metabolism‬ - ‪Drug delivery‬ - ‪Cancer Pharmacology‬ - ‪Prodrug design‬"><meta property="og:title" content="Paul Loadman"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"bB5AYYu0Aci1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=7MtgsawAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUFv7NETqEsxd7lxbcjYzqLlRSnloaCE"><input type="hidden" name="user" value="7MtgsawAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">5053</td><td class="gsc_rsb_std">2234</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">42</td><td class="gsc_rsb_std">26</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">90</td><td class="gsc_rsb_std">57</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1154px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1112px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">460</div><div class="gsc_g_xtl" style="top:73px;">230</div><div class="gsc_g_xtl" style="top:113px;">115</div><div class="gsc_g_xtl" style="top:33px;">345</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:1059px">1988</span><span class="gsc_g_t" style="right:1027px">1989</span><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1064px;top:154px;height:6px;z-index:34"><span class="gsc_g_al">19</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1032px;top:150px;height:10px;z-index:33"><span class="gsc_g_al">29</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:149px;height:11px;z-index:32"><span class="gsc_g_al">33</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:143px;height:17px;z-index:31"><span class="gsc_g_al">51</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:149px;height:11px;z-index:30"><span class="gsc_g_al">34</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:154px;height:6px;z-index:29"><span class="gsc_g_al">18</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:155px;height:5px;z-index:28"><span class="gsc_g_al">15</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:155px;height:5px;z-index:27"><span class="gsc_g_al">16</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:152px;height:8px;z-index:26"><span class="gsc_g_al">24</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:156px;height:4px;z-index:25"><span class="gsc_g_al">12</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:155px;height:5px;z-index:24"><span class="gsc_g_al">16</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:150px;height:10px;z-index:23"><span class="gsc_g_al">29</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:148px;height:12px;z-index:22"><span class="gsc_g_al">35</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:143px;height:17px;z-index:21"><span class="gsc_g_al">49</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:142px;height:18px;z-index:20"><span class="gsc_g_al">52</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:139px;height:21px;z-index:19"><span class="gsc_g_al">63</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:131px;height:29px;z-index:18"><span class="gsc_g_al">85</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:127px;height:33px;z-index:17"><span class="gsc_g_al">97</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:124px;height:36px;z-index:16"><span class="gsc_g_al">105</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:95px;height:65px;z-index:15"><span class="gsc_g_al">187</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:101px;height:59px;z-index:14"><span class="gsc_g_al">170</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:98px;height:62px;z-index:13"><span class="gsc_g_al">180</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:100px;height:60px;z-index:12"><span class="gsc_g_al">175</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:87px;height:73px;z-index:11"><span class="gsc_g_al">212</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:86px;height:74px;z-index:10"><span class="gsc_g_al">213</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:68px;height:92px;z-index:9"><span class="gsc_g_al">266</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:63px;height:97px;z-index:8"><span class="gsc_g_al">281</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:58px;height:102px;z-index:7"><span class="gsc_g_al">295</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:45px;height:115px;z-index:6"><span class="gsc_g_al">333</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:35px;height:125px;z-index:5"><span class="gsc_g_al">361</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:33px;height:127px;z-index:4"><span class="gsc_g_al">367</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:32px;height:128px;z-index:3"><span class="gsc_g_al">369</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:5px;height:155px;z-index:2"><span class="gsc_g_al">448</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:39px;height:121px;z-index:1"><span class="gsc_g_al">350</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=7MtgsawAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3d7MtgsawAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>34 articles</span></div><div class="gsc_rsb_m_na"><div>3 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:8%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Paul Loadman" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Paul Loadman</div><div class="gsc_prf_il">Professor of Pharmacokinetics and Drug Metabolism, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=4189814768881843562" class="gsc_prf_ila">University of Bradford</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at Bradford.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:pharmacokinetics" class="gsc_prf_inta gs_ibl">Pharmacokinetics</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:drug_metabolism" class="gsc_prf_inta gs_ibl">Drug metabolism</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:drug_delivery" class="gsc_prf_inta gs_ibl">Drug delivery</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cancer_pharmacology" class="gsc_prf_inta gs_ibl">Cancer Pharmacology</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:prodrug_design" class="gsc_prf_inta gs_ibl">Prodrug design</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUFv7NETqEsxd7lxbcjYzqLlRSnloaCE"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=7MtgsawAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota</a><div class="gs_gray">H Watson, S Mitra, FC Croden, M Taylor, HM Wood, SL Perry, JA Spencer, ...</div><div class="gs_gray">Gut 67 (11), 1974-1983<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1413424561968650535" class="gsc_a_ac gs_ibl">191</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Fiber management drawer and sliding cable slack limiter</a><div class="gs_gray">M Kim, MJ Wentworth, TD Smith</div><div class="gs_gray">US Patent 6,748,155<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4853782443174429583,11050292608459541584" class="gsc_a_ac gs_ibl">186</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy</a><div class="gs_gray">MC Bibby, JA Double, PM Loadman, CV Duke</div><div class="gs_gray">JNCI: Journal of the National Cancer Institute 81 (3), 216-220<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10041440309414740254" class="gsc_a_ac gs_ibl">148</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Design, Synthesis, and Biophysical and Biological Evaluation of a Series of Pyrrolobenzodiazepine−Poly(<i>N</i>-methylpyrrole) Conjugates</a><div class="gs_gray">G Wells, CRH Martin, PW Howard, ZA Sands, CA Laughton, A Tiberghien, ...</div><div class="gs_gray">Journal of medicinal chemistry 49 (18), 5442-5461<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4133984824695775632" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for <i>in situ</i> proteomic investigation of&nbsp;…</a><div class="gs_gray">MC Djidja, S Francese, PM Loadman, CW Sutton, P Scriven, E Claude, ...</div><div class="gs_gray">Proteomics 9 (10), 2750-2763<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=700673623629203897" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate</a><div class="gs_gray">IG Kirwan, PM Loadman, DJ Swaine, DA Anthoney, GR Pettit, JW Lippert, ...</div><div class="gs_gray">Clinical Cancer Research 10 (4), 1446-1453<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11230016381767459628" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: Implications for drug development1</a><div class="gs_gray">P Gibson, JH Gill, PA Khan, JM Seargent, SW Martin, PA Batman, J Griffith, ...</div><div class="gs_gray">Molecular cancer therapeutics 2 (6), 527-534<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15843947570550526292" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study</a><div class="gs_gray">MR Albertella, PM Loadman, PH Jones, RM Phillips, R Rampling, ...</div><div class="gs_gray">Clinical Cancer Research 14 (4), 1096-1104<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7107039844551382571" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors</a><div class="gs_gray">D Hochhauser, T Meyer, VJ Spanswick, J Wu, PH Clingen, P Loadman, ...</div><div class="gs_gray">Clinical Cancer Research 15 (6), 2140-2147<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6132452778530646671" class="gsc_a_ac gs_ibl">124</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Development of novel tumor‐targeted theranostic nanoparticles activated by membrane‐type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy</a><div class="gs_gray">C Ansari, GA Tikhomirov, SH Hong, RA Falconer, PM Loadman, JH Gill, ...</div><div class="gs_gray">Small 10 (3), 566-575<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10817522521664937039" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma.</a><div class="gs_gray">K Grosios, PM Loadman, DJ Swaine, GR Pettit, MC Bibby</div><div class="gs_gray">Anticancer research 20 (1A), 229-233<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6911602228874577584" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix‐assisted laser desorption/ionisation mass&nbsp;…</a><div class="gs_gray">SJ Atkinson, PM Loadman, C Sutton, LH Patterson, MR Clench</div><div class="gs_gray">Rapid Communications in Mass Spectrometry: An International Journal Devoted&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9645413553257638156" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study</a><div class="gs_gray">GJS Rustin, C Bradley, S Galbraith, M Stratford, P Loadman, S Waller, ...</div><div class="gs_gray">British journal of cancer 88 (8), 1160-1167<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6830680260174782055" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours</a><div class="gs_gray">RM Phillips, PM Loadman, BP Cronin</div><div class="gs_gray">British journal of cancer 77 (12), 2112-2119<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2313357777054799618" class="gsc_a_ac gs_ibl">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas</a><div class="gs_gray">JH Gill, IG Kirwan, JM Seargent, SW Martin, S Tijani, VA Anikin, ...</div><div class="gs_gray">Neoplasia 6 (6), 777-785<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17768582889239180604" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:HDshCWvjkbEC" class="gsc_a_at">FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms</a><div class="gs_gray">DC Tomlinson, EW Baxter, PM Loadman, MA Hull, MA Knowles</div><div class="gs_gray">PloS one 7 (6), e38972<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17603666708652782901" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling human colorectal cancer cells</a><div class="gs_gray">G Hawcroft, PM Loadman, A Belluzzi, MA Hull</div><div class="gs_gray">Neoplasia 12 (8), 618-IN2<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1060316650860932517" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid</a><div class="gs_gray">AJ Cockbain, M Volpato, AD Race, A Munarini, C Fazio, A Belluzzi, ...</div><div class="gs_gray">Gut 63 (11), 1760-1768<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3657030683439036509" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Proteases in cancer drug delivery</a><div class="gs_gray">J Vandooren, G Opdenakker, PM Loadman, DR Edwards</div><div class="gs_gray">Advanced drug delivery reviews 97, 144-155<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9653115551865121956" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;citation_for_view=7MtgsawAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1</a><div class="gs_gray">PM Loadman, MC Bibby, JA Double, WM Al-Shakhaa, R Duncan</div><div class="gs_gray">Clinical cancer research 5 (11), 3682-3688<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18186410711794587554" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis‐associated colorectal cancer acting on Notch signaling and gut microbiota</a><div class="gs_gray">G Piazzi, G D'Argenio, A Prossomariti, V Lembo, G Mazzone, M Candela, ...</div><div class="gs_gray">International journal of cancer 135 (9), 2004-2013<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15847137337047329400" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind&nbsp;…</a><div class="gs_gray">MA Hull, K Sprange, T Hepburn, W Tan, A Shafayat, CJ Rees, G Clifford, ...</div><div class="gs_gray">The Lancet 392 (10164), 2583-2594<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10058184007242399045" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)</a><div class="gs_gray">MC Bibby, JA Double, RM Phillips, PM Loadman</div><div class="gs_gray">British journal of cancer 55 (2), 159-163<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14623329035658155522" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression&nbsp;…</a><div class="gs_gray">JM Atkinson, CJ Pennington, SW Martin, VA Anikin, AJ Mearns, ...</div><div class="gs_gray">European journal of cancer 43 (11), 1764-1771<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13586693176437520968" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agent</a><div class="gs_gray">GP Wilkinson, JP Taylor, S Shnyder, P Cooper, PW Howard, DE Thurston, ...</div><div class="gs_gray">Investigational new drugs 22 (3), 231-240<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=55348479980556572" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex</a><div class="gs_gray">SD Shnyder, Y Fu, A Habtemariam, SH van Rijt, PA Cooper, PM Loadman, ...</div><div class="gs_gray">MedChemComm 2 (7), 666-668<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3204240173250597715" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability</a><div class="gs_gray">H Benelkebir, S Marie, AL Hayden, J Lyle, PM Loadman, SJ Crabb, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 19 (12), 3650-3658<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7173665193379765760" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases</a><div class="gs_gray">JM Atkinson, RA Falconer, DR Edwards, CJ Pennington, CS Siller, ...</div><div class="gs_gray">Cancer research 70 (17), 6902-6912<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7021443758599245458" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs</a><div class="gs_gray">RM Phillips, J Pearce, PM Loadman, MC Bibby, PA Cooper, DJ Swaine, ...</div><div class="gs_gray">Cancer research 58 (23), 5263-5266<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6116472444337078012" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:qUcmZB5y_30C" class="gsc_a_at">The omega‐3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC‐26 colorectal cancer cell liver metastasis via inhibition of PGE<sub>2</sub>‐dependent cell&nbsp;…</a><div class="gs_gray">G Hawcroft, M Volpato, G Marston, N Ingram, SL Perry, AJ Cockbain, ...</div><div class="gs_gray">British journal of pharmacology 166 (5), 1724-1737<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5578767322101198745" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Pharmacological and biological evaluation of a series of substituted 1, 4-naphthoquinone bioreductive drugs</a><div class="gs_gray">RM Phillips, M Jaffar, DJ Maitland, PM Loadman, SD Shnyder, G Steans, ...</div><div class="gs_gray">Biochemical pharmacology 68 (11), 2107-2116<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8208482677509110224" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug&nbsp;…</a><div class="gs_gray">RM Phillips, AM Burger, PM Loadman, CM Jarrett, DJ Swaine, HH Fiebig</div><div class="gs_gray">Cancer Research 60 (22), 6384-6390<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17147687766822445423" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins</a><div class="gs_gray">S Travica, K Pors, PM Loadman, SD Shnyder, I Johansson, MN Alandas, ...</div><div class="gs_gray">Clinical Cancer Research 19 (11), 2952-2961<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15595253743830407569" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer</a><div class="gs_gray">R Puri, V Palit, PM Loadman, M Flannigan, T Shah, GA Choudry, S Basu, ...</div><div class="gs_gray">The Journal of urology 176 (4), 1344-1348<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14396665495785089709" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration</a><div class="gs_gray">YMJ Al-Saraireh, M Sutherland, BR Springett, F Freiberger, ...</div><div class="gs_gray">PLoS One 8 (8), e73366<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17786341933495416652" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2, 5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1, 4-benzoquinone), in mice</a><div class="gs_gray">PM Loadman, RM Phillips, LE Lim, MC Bibby</div><div class="gs_gray">Biochemical pharmacology 59 (7), 831-837<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17549897268705077750" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Pharmacokinetic drug interactions with anticancer drugs</a><div class="gs_gray">PM Loadman, MC Bibby</div><div class="gs_gray">Clinical pharmacokinetics 26 (6), 486-500<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=811001806199244150" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:HE397vMXCloC" class="gsc_a_at">A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening&nbsp;…</a><div class="gs_gray">MA Hull, AC Sandell, AA Montgomery, RFA Logan, GM Clifford, CJ Rees, ...</div><div class="gs_gray">Trials 14 (1), 1-11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18036586494862682607" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder</a><div class="gs_gray">M Sutherland, JH Gill, PM Loadman, JP Laye, HM Sheldrake, ...</div><div class="gs_gray">Molecular cancer therapeutics 12 (1), 27-37<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12616942295041132581" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine PBD) dimer.</a><div class="gs_gray">PW Howard, ZZ Chen, SJ Gregson, M Stephenson, S Klee, J Hartley, ...</div><div class="gs_gray">AMER ASSOC CANCER RESEARCH 11 (24), 9015S-9016S<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3243183510409423013" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Chemical synthesis and biological evaluation of a NAD (P) H: quinone oxidoreductase-1–targeted tripartite quinone drug delivery system</a><div class="gs_gray">M Volpato, N Abou-Zeid, RW Tanner, LT Glassbrook, J Taylor, I Stratford, ...</div><div class="gs_gray">Molecular cancer therapeutics 6 (12), 3122-3130<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11122099763974166654" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study</a><div class="gs_gray">WP Steward, M Middleton, A Benghiat, PM Loadman, C Hayward, ...</div><div class="gs_gray">Annals of oncology 18 (6), 1098-1103<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1746588837845253011" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Pharmacokinetics, metabolism &amp; glutathione reactivity of SJG-136</a><div class="gs_gray">GP Wilkinson, PM Loadman, TC Jenkins, J Taylor, SD Shnyder, ...</div><div class="gs_gray">British Journal of Cancer 88, S29-S29<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16748106498332534956" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Pharmacokinetic and intracellular pharmacological characteristics of the novel pyrrolobenzodiazepine (PBD) dimmer SJG-136</a><div class="gs_gray">GP Wilkinson, P Loadman, J Taylor, TC Jenkins, D Swaine, JA Double, ...</div><div class="gs_gray">Proceeding of the American Association for Cancer Research 44, 1634-<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1569725393393908180" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:hC7cP41nSMkC" class="gsc_a_at">In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts</a><div class="gs_gray">KJ Williams, MR Albertella, B Fitzpatrick, PM Loadman, SD Shnyder, ...</div><div class="gs_gray">Molecular cancer therapeutics 8 (12), 3266-3275<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9485376419108531275" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma</a><div class="gs_gray">JM Seargent, PM Loadman, SW Martin, B Naylor, MC Bibby, JH Gill</div><div class="gs_gray">Urology 65 (4), 815-820<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16009831086142372089" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Carbon isotope discrimination: potential for screening salinity tolerance in rice at the seedling stage using hydroponics</a><div class="gs_gray">R Shaheen, RC Hood‐Nowotny</div><div class="gs_gray">Plant Breeding 124 (3), 220-224<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2969376667796580165" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9</a><div class="gs_gray">PM Loadman, MC Bibby, RM Phillips</div><div class="gs_gray">British journal of pharmacology 137 (5), 701-709<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17087119605136529086" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity</a><div class="gs_gray">K Pors, PM Loadman, SD Shnyder, M Sutherland, HM Sheldrake, ...</div><div class="gs_gray">Chemical Communications 47 (44), 12062-12064<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16282630586246725181" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours</a><div class="gs_gray">N Isambert, M Campone, E Bourbouloux, M Drouin, A Major, W Yin, ...</div><div class="gs_gray">European Journal of Cancer 46 (4), 729-734<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=50717535950661823" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Immunohistochemical analysis of NAD (P) H: quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour&nbsp;…</a><div class="gs_gray">S Basu, JE Brown, GM Flannigan, JH Gill, PM Loadman, SW Martin, ...</div><div class="gs_gray">International journal of cancer 109 (5), 703-709<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1759493332039585186" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon</a><div class="gs_gray">JA Double, MC Bibby, PM Loadman</div><div class="gs_gray">British journal of cancer 54 (4), 595-600<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9656538881196915818" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment</a><div class="gs_gray">SM Elkashef, SJ Allison, M Sadiq, HA Basheer, GR Morais, PM Loadman, ...</div><div class="gs_gray">Scientific reports 6 (1), 1-11<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7655258333166009774" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Mathematical and computational models of drug transport in tumours</a><div class="gs_gray">CM Groh, ME Hubbard, PF Jones, PM Loadman, N Periasamy, ...</div><div class="gs_gray">Journal of The Royal Society Interface 11 (94), 20131173<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10590974471321863198" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity</a><div class="gs_gray">HM Sheldrake, S Travica, I Johansson, PM Loadman, M Sutherland, ...</div><div class="gs_gray">Journal of medicinal chemistry 56 (15), 6273-6277<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10859828525601925772" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Synthesis and biological evaluation of colchicine B-ring analogues tethered with halogenated benzyl moieties</a><div class="gs_gray">L Cosentino, M Redondo-Horcajo, Y Zhao, AR Santos, KF Chowdury, ...</div><div class="gs_gray">Journal of medicinal chemistry 55 (24), 11062-11066<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13078926363268587443" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Formation of DNA interstrand cross-links as a marker of Mitomycin C bioreductive activation and chemosensitivity</a><div class="gs_gray">M Volpato, J Seargent, PM Loadman, RM Phillips</div><div class="gs_gray">European Journal of Cancer 41 (9), 1331-1338<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6538842524339380768" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Separation methods for anthraquinone related anti-cancer drugs</a><div class="gs_gray">PM Loadman, CR Calabrese</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 764 (1-2&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17505318668820959909" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">A preclinical pharmacokinetic study of the bioreductive drug AQ4N</a><div class="gs_gray">PM Loadman, DJ Swaine, MC Bibby, KJ Welham, LH Patterson</div><div class="gs_gray">Drug metabolism and disposition 29 (4), 422-426<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4198426157720887200" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">A Novel Theranostic Strategy for MMP-14–Expressing Glioblastomas Impacts Survival</a><div class="gs_gray">S Mohanty, Z Chen, K Li, GR Morais, J Klockow, K Yerneni, L Pisani, ...</div><div class="gs_gray">Molecular cancer therapeutics 16 (9), 1909-1921<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11396729082536646477" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512)</a><div class="gs_gray">MC Bibby, JA Double, PM Loadman</div><div class="gs_gray">British journal of cancer 58 (3), 341-344<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15939743475001203661" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimens</a><div class="gs_gray">BJ McDermott, JA Double, MC Bibby, DEV Wilman, PM Loadman, ...</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 338, 335-345<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10763502358424944788" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Identification of stage-specific breast markers using quantitative proteomics</a><div class="gs_gray">S Shaheed, N Rustogi, A Scally, J Wilson, H Thygesen, MA Loizidou, ...</div><div class="gs_gray">Journal of proteome research 12 (12), 5696-5708<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14619620721796315693" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: Synthesis, DNA interaction, cytotoxicity and differential cellular localization</a><div class="gs_gray">G Wells, M Suggitt, M Coffils, MAH Baig, PW Howard, PM Loadman, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 18 (6), 2147-2151<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3865182897069358068" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:5nxA0vEk-isC" class="gsc_a_at">ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour</a><div class="gs_gray">JRW Masters, BJ McDermott, S Harland, MC Bibby, PM Loadman</div><div class="gs_gray">Cancer chemotherapy and pharmacology 38 (1), 59-64<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14353217413445444591" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Synthesis and biological evaluation of colchicine C-ring analogues tethered with aliphatic linkers suitable for prodrug derivatisation</a><div class="gs_gray">J Fournier-Dit-Chabert, V Vinader, AR Santos, M Redondo-Horcajo, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 22 (24), 7693-7696<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=120544642316738811" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity</a><div class="gs_gray">JH Gill, PM Loadman, SD Shnyder, P Cooper, JM Atkinson, ...</div><div class="gs_gray">Molecular pharmaceutics 11 (4), 1294-1300<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5020312989116329490" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research</a><div class="gs_gray">H Bateson, S Saleem, PM Loadman, CW Sutton</div><div class="gs_gray">Journal of pharmacological and toxicological methods 64 (3), 197-206<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9656604292196674834" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:k_IJM867U9cC" class="gsc_a_at">A mathematical model of doxorubicin penetration through multicellular layers</a><div class="gs_gray">CJ Evans, RM Phillips, PF Jones, PM Loadman, BD Sleeman, CJ Twelves, ...</div><div class="gs_gray">Journal of theoretical biology 257 (4), 598-608<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18216062100856046674" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass</a><div class="gs_gray">P Kant, SL Perry, SP Dexter, AD Race, PM Loadman, MA Hull</div><div class="gs_gray">Obesity 22 (1), 202-210<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=236871661533865012" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:TQgYirikUcIC" class="gsc_a_at">Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)</a><div class="gs_gray">AM Burger, PM Loadman, DE Thurston, R Schultz, HH Fiebig, MC Bibby</div><div class="gs_gray">Journal of chemotherapy 19 (1), 66-78<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17953136518748786607" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">J. Boos, Electrophoresis J. Boos, Electrophoresis 19, 2939, 1998</a><div class="gs_gray">PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4155781456889922200" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Thin‐layer chromatography/matrix‐assisted laser desorption/ionisation mass spectrometry and matrix‐assisted laser desorption/ionisation mass spectrometry imaging for the&nbsp;…</a><div class="gs_gray">A Batubara, VA Carolan, PM Loadman, C Sutton, SD Shnyder, ...</div><div class="gs_gray">Rapid communications in mass spectrometry 29 (14), 1288-1296<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1597894595461681499" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Potential of AG in the treatment of breast cancer</a><div class="gs_gray">J Stanslas, PS Liew, N Iftikhar, CP Lee, S Saad, N Lajis, RA Robins, ...</div><div class="gs_gray">European Journal of Cancer 37, S169-S169<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14358527258038791406" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:aqlVkmm33-oC" class="gsc_a_at">High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide</a><div class="gs_gray">DJ Swaine, PM Loadman, MC Bibby, MA Graham, LH Patterson</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 742 (2&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16097576666815829124" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:4DMP91E08xMC" class="gsc_a_at">Potentiation of EO9 anti-tumour activity by hydralazine</a><div class="gs_gray">MC Bibby, NR Sleigh, PM Loadman, JA Double</div><div class="gs_gray">European Journal of Cancer 29 (7), 1033-1035<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18241775415463753299" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:IWHjjKOFINEC" class="gsc_a_at">NAD (P) H: Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to&nbsp;…</a><div class="gs_gray">S Basu, JE Brown, GM Flannigan, JH Gill, PM Loadman, SW Martin, ...</div><div class="gs_gray">International journal of oncology 25 (4), 921-928<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3239067171352997641" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:dhFuZR0502QC" class="gsc_a_at">The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor model</a><div class="gs_gray">RM Phillips, MC Bibby, JA Double, PM Loadman</div><div class="gs_gray">The International Journal of Cell Cloning 9 (2), 144-154<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4576512302403905649" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">In vivo metabolism of the antitumor imidazoacridinone C1311 in the mouse and in vitro comparison with humans</a><div class="gs_gray">CR Calabrese, PM Loadman, LSE Lim, MC Bibby, JA Double, JE Brown, ...</div><div class="gs_gray">Drug metabolism and disposition 27 (2), 240-245<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17961223715445423451" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice</a><div class="gs_gray">CR Calabrese, MC Bibby, JA Double, PM Loadman</div><div class="gs_gray">Cancer chemotherapy and pharmacology 42 (5), 379-385<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4040749000450493768" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">A liquid chromatography–tandem mass spectrometry method to measure fatty acids in biological samples</a><div class="gs_gray">M Volpato, JA Spencer, AD Race, A Munarini, A Belluzzi, AJ Cockbain, ...</div><div class="gs_gray">Journal of Chromatography B 1055, 125-134<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18033594369740858999" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Method development for protein profiling in biological tissues by matrix‐assisted laser desorption/ionisation mass spectrometry imaging</a><div class="gs_gray">MC Djidja, V Carolan, PM Loadman, MR Clench</div><div class="gs_gray">Rapid Communications in Mass Spectrometry: An International Journal Devoted&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8079972525165925584" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Thio TEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80</a><div class="gs_gray">JRW Masters, BJ McDermott, WEA Jenkins, E Fenwick, PJR Shah, ...</div><div class="gs_gray">Cancer chemotherapy and pharmacology 25 (4), 267-273<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15105917418602932463" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice</a><div class="gs_gray">MC Bibby, PM Loadman, AF Al-Ghabban, JA Double</div><div class="gs_gray">British journal of cancer 65 (3), 347-350<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14342233728817990246" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases</a><div class="gs_gray">H Watson, AJ Cockbain, J Spencer, A Race, M Volpato, PM Loadman, ...</div><div class="gs_gray">Prostaglandins, Leukotrienes and Essential Fatty Acids 115, 60-66<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4821796984679113853" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:a0OBvERweLwC" class="gsc_a_at">Cancer Therapy: Development of Novel Tumor‐Targeted Theranostic Nanoparticles Activated by Membrane‐Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance&nbsp;…</a><div class="gs_gray">C Ansari, GA Tikhomirov, SH Hong, RA Falconer, PM Loadman, JH Gill, ...</div><div class="gs_gray">Small 10 (3), 417-417<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1573351473723651428" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:mB3voiENLucC" class="gsc_a_at">Experimental anti-tumor effects of flavone acetic acid (LM975)</a><div class="gs_gray">MC Bibby, JA Double, RM Phillips, PM Loadman, JA Gummer</div><div class="gs_gray">Progress in clinical and biological research 280, 243-246<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12910954199353523619" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method</a><div class="gs_gray">S Kamble, P Loadman, MH Abraham, X Liu</div><div class="gs_gray">Journal of pharmaceutical and biomedical analysis 149, 16-21<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15417809331991573899" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action</a><div class="gs_gray">M Suggitt, J Fearnley, DJ Swaine, M Volpato, RM Phillips, MC Bibby, ...</div><div class="gs_gray">Teratogenesis, carcinogenesis, and mutagenesis 23 (S2), 13-29<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16487760216298591552" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance</a><div class="gs_gray">M Jove, J Spencer, M Clench, PM Loadman, C Twelves</div><div class="gs_gray">Critical reviews in oncology/hematology 141, 153-162<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3848408985054880351" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Detection of (NAD (P) H: Quinone oxidoreductase-1, EC 1.6. 99.2) 609C↷ T and 465C↷ T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP</a><div class="gs_gray">RM Phillips, S Basu, JE Brown, GM Flannigan, PM Loadman, SW Martin, ...</div><div class="gs_gray">International journal of oncology 24 (4), 1005-1010<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15530667646517979430" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Theranostic nanoparticles enhance the response of glioblastomas to radiation</a><div class="gs_gray">W Wu, JL Klockow, S Mohanty, KS Ku, M Aghighi, S Melemenidis, Z Chen, ...</div><div class="gs_gray">Nanotheranostics 3 (4), 299<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13616322492647239936" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Compounds</a><div class="gs_gray">R Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 8,927,486<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1360123026917107013" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:WqliGbK-hY8C" class="gsc_a_at">A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of the selective aurora kinase inhibitor GSK1070916A.</a><div class="gs_gray">I McNeish, A Anthoney, P Loadman, D Berney, S Joel, SER Halford, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), 2525-2525<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3883747069515559022" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Phase 1 dose escalation study of AQ4N, a selective hypoxic cell cytotoxin, with fractionated radiotherapy (RT): First report</a><div class="gs_gray">A Benghiat, WP Steward, PM Loadman, M Middleton, D Talbot, ...</div><div class="gs_gray">Journal of clinical oncology 22 (14_suppl), 2091-2091<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17111529248338820593" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein</a><div class="gs_gray">DA Dart, MS Mansoor, PM Loadman, SM Picksley</div><div class="gs_gray">Expert Opinion on Therapeutic Patents 11 (12), 1825-1835<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=426297930393295153" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours</a><div class="gs_gray">MC Bibby, BJ McDermott, JA Double, RM Phillips, PM Loadman, ...</div><div class="gs_gray">Cancer chemotherapy and pharmacology 20 (3), 203-206<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16113822401583748137" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:otzGkya1bYkC" class="gsc_a_at">Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and&nbsp;…</a><div class="gs_gray">N Ingram, LE McVeigh, RH Abou-Saleh, J Maynard, SA Peyman, ...</div><div class="gs_gray">Theranostics 10 (24), 10973<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7201652241145393539" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Recent advances in the analysis of polysialic acid from complex biological systems</a><div class="gs_gray">X Guo, SM Elkashef, PM Loadman, LH Patterson, RA Falconer</div><div class="gs_gray">Carbohydrate polymers 224, 115145<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11854224803371041599" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7MtgsawAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Drug delivery in a tumour cord model: a computational simulation</a><div class="gs_gray">ME Hubbard, M Jove, PM Loadman, RM Phillips, CJ Twelves, SW Smye</div><div class="gs_gray">Royal Society open science 4 (5), 170014<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14589558496699160846" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:maZDTaKrznsC" class="gsc_a_at">Pyrrolobenzodiazepine-polyamide libraries: synthesis and DNA binding selectivity</a><div class="gs_gray">G Wells, T Gale, A Hardy, A Hamaguchi, J Hartley, G Wilkinson, ...</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 55, S16-S17<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7777272790623541828" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography</a><div class="gs_gray">CR Calabrese, PM Loadman</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 690 (1-2&nbsp;…<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11294477739653121756" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Extraction of the synthetic lytic peptide, cecropin B, from biological fluid and analysis using reversed-phase high-performance liquid chromatography</a><div class="gs_gray">AJ Moore, PM Loadman, DA Devine, MC Bibby</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 672 (2&nbsp;…<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10860408845863836485" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models</a><div class="gs_gray">M Jove, JA Spencer, ME Hubbard, EC Holden, RD O’Dea, BS Brook, ...</div><div class="gs_gray">Journal of Pharmacology and Experimental Therapeutics 370 (2), 242-251<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7174070500830338760" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:D_sINldO8mEC" class="gsc_a_at">Targeting of Hypoxia in AQ4N-treated Tumour Xenografts by MALDIIon Mobility Separation-Mass Spectrometry Imaging</a><div class="gs_gray">MC Djidja, S Francese, E Claude, P Loadman, C Sutton, S Shynder, ...</div><div class="gs_gray">Current Analytical Chemistry 9 (2), 212-225<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13207488153205155935" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Phase 1 Study Of A Sequence Selective Minor Groove DNA Binding Agent (SJG-136) with Pharmacokinetic and Pharmacodynamic Measurements in Patients with Advanced Solid Tumours.</a><div class="gs_gray">D Hochhauser, T Meyer, VJ Spanswick, J Wu, PH Clingen, PM Loadman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1984095285047114368" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Evaluation of the safety of C-1311 administered in a phase I dose-escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumors</a><div class="gs_gray">N Isambert, M Campone, E Bourbouloux, M Drouin, A Major, P Loadman, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 2069-2069<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7693167932720003298" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Tumor-specific activation of the hypoxic cell cytotoxin AQ4N: a phase I clinical study in solid tumors</a><div class="gs_gray">PA Harris, CR Dunk, MR Albertella, PM Loadman, RM Phillips, P Jones, ...</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 571-572<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12152255577659273391" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:hMod-77fHWUC" class="gsc_a_at">Phase I clinical evaluation of intravesical EOquin (EO9) against superficial bladder cancer: Preliminary results.</a><div class="gs_gray">R Puri, S Basu, P Loadman, SW Martin, V Palit, G Lenaz, C Van Kalken, ...</div><div class="gs_gray">Clinical Cancer Research 9 (16), 6248S-6249S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=22419075180342283" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Pharmacokinetics and anti-tumour activity of B. 4152, a reactive molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, and its uracil analogue.</a><div class="gs_gray">PM Loadman, AM Matthew, JE McCormick, RS McElhinney, MC Bibby</div><div class="gs_gray">Anti-cancer drug design 11 (2), 117-128<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16627476036243685858" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Progress towards a clinically-successful ATR inhibitor for cancer therapy</a><div class="gs_gray">FM Barnieh, PM Loadman, RA Falconer</div><div class="gs_gray">Current Research in Pharmacology and Drug Discovery, 100017<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9433359531875561714" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">FIESTA: A phase Ib and pharmacokinetic trial of AZD4547 in combination with gemcitabine and cisplatin.</a><div class="gs_gray">RH Jones, DA Anthoney, RJ Jones, SJ Crabb, SA Hussain, AJ Birtle, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 4521-4521<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1879128902236437235" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:M7yex6snE4oC" class="gsc_a_at">Design of tumour-activated oligopeptide prodrugs that exploit the proteolytic activity of matrix metalloproteinases</a><div class="gs_gray">DJ Mincher, PM Loadman, J Lyle, A Di Salvo, A Turnbull, MC Bibby, ...</div><div class="gs_gray">European Journal of Cancer 38, S121-S121<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1052490295288226986" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Pharmacokinetics and cytotoxicity of B. 3839, a molecular combination of 5-fluorouracil and n-(2-chloroethyl)-n-nitrosourea, in a mouse model</a><div class="gs_gray">PM Loadman, MC Bibby, JA Double, RS McElhinney</div><div class="gs_gray">Investigational new drugs 10 (3), 149-158<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13997373988613035689" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:blknAaTinKkC" class="gsc_a_at">Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations</a><div class="gs_gray">JA Double, MC Bibby, PM Loadman, JC Bloomer</div><div class="gs_gray">European Journal of Cancer and Clinical Oncology 24 (8), 1355-1360<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13216706449710701546" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Rationalized computer-aided design of matrix-metalloprotease-selective prodrugs</a><div class="gs_gray">M Jain, JJ Harburn, JH Gill, PM Loadman, RA Falconer, CA Mooney, ...</div><div class="gs_gray">Journal of medicinal chemistry 60 (10), 4496-4502<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2274115435508453566" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:hMsQuOkrut0C" class="gsc_a_at">An optimised assay for quantitative, high-throughput analysis of polysialyltransferase activity</a><div class="gs_gray">SM Elkashef, M Sutherland, LH Patterson, PM Loadman, RA Falconer</div><div class="gs_gray">Analyst 141 (20), 5849-5856<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5143860777759414270" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Probing cytochrome P450-mediated activation with a truncated azinomycin analogue</a><div class="gs_gray">V Vinader, M Sadiq, M Sutherland, M Huang, PM Loadman, L Elsalem, ...</div><div class="gs_gray">MedChemComm 6 (1), 187-191<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6034452845104129399" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog</a><div class="gs_gray">CC Wong, N Periasamy, SR Sagineedu, S Sidik, SH Sumon, P Loadman, ...</div><div class="gs_gray">Investigational new drugs 32 (5), 806-814<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15277480618623941664" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:35r97b3x0nAC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray">US Patent 8,691,751<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10636189456359704705" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Growth factor</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray">US Patent App. 12/595,482<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1882865743494383520" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:rO6llkc54NcC" class="gsc_a_at">Evaluation of the safety of C-1311 administered in a phase 1 dose-escalation trial as a 1-hour infusion once every 3 weeks in patients with advanced solid tumors</a><div class="gs_gray">A Thomas, A Anthoney, S Ahmed, M Drouin, A Major, RL Capizzi, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 12005-12005<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15382615745886412159" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT</a><div class="gs_gray">MA Hull, K Sprange, T Hepburn, W Tan, A Shafayat, CJ Rees, G Clifford, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11856231267256847841" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative&nbsp;…</a><div class="gs_gray">CHH Ottensmeier, T Jones, JJ Sacco, JA McCaul, P Brennan, C Paterson, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (15_suppl), 6068-6068<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1273903579090153775" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:rmuvC79q63oC" class="gsc_a_at">Membrane-type matrix metalloproteinases: expression, roles in metastatic prostate cancer progression and opportunities for drug targeting</a><div class="gs_gray">RA Falconer, PM Loadman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17364455309744353990" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Wnt Signaling as a therapeutic target in cancer and metastasis</a><div class="gs_gray">R Morgan, R Ankrah, S El-Tanani, PM Loadman, L Pattterson, ...</div><div class="gs_gray">Introduction to cancer metastasis, 375-394<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1948778185275538675" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 9,358,303<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5906752606499711395" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">PWE-163 Chemr23 and BLT1 Receptor Expression in Colorectal Cancer</a><div class="gs_gray">JM Hutchinson, M Volpato, P Loadman, A Nicolaou, M Hull</div><div class="gs_gray">Gut 62 (Suppl 1), A196-A197<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18428315566427770912" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signalling in human colorectal cancer cells.</a><div class="gs_gray">G Hawcroft, PM Loadman, A Belluzzi, MA Hull</div><div class="gs_gray">Neoplasia Press<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6600122896138651288" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:7wO8s98CvbsC" class="gsc_a_at">MMP activated vascular disrupting agents</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16692996098446099918,18156584382340153755" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:z_wVstp3MssC" class="gsc_a_at">Membrane type 1-matrix metalloproteinase (MT1-MMP) targeted antitumor agents</a><div class="gs_gray">J Atkinson, R Falconer, C Pennington, S Martin, D Edwards, L Patterson, ...</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 2453-2453<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17457717695321821899" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:GnPB-g6toBAC" class="gsc_a_at">In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts</a><div class="gs_gray">MR Albertella, PM Loadman, KJ Williams, SD Shnyder, RM Phillips, ...</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 314-314<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5558008670225067624" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Practical aspects of pharmacokinetics and pharmacodynamics</a><div class="gs_gray">C Twelves, M JOVE, P LOADMAN</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12438156953477804947" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Design of tumour-activated prodrugs that harness the'dark side'of MMP-9</a><div class="gs_gray">L Young, A Di Salvo, A Turnbull, J Lyle, MC Bibby, JA Double, G Kay, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S27-S27<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17592447548212028380" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ALROH1vI_8AC" class="gsc_a_at">How can the potential of the duocarmycins be unlocked for cancer therapy?</a><div class="gs_gray">Z Jukes, GR Morais, PM Loadman, K Pors</div><div class="gs_gray">Drug Discovery Today<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8756480951303127772" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:lvd772isFD0C" class="gsc_a_at">Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer</a><div class="gs_gray">RM Phillips, PM Loadman, G Reddy</div><div class="gs_gray">Cancer chemotherapy and pharmacology 83 (6), 1183-1189<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5217199173070536256" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">A study of inter-individual variability in the Phase II metabolism of xenobiotics in human skin</a><div class="gs_gray">S Spriggs, R Cubberley, P Loadman, D Sheffield, A Wierzbicki</div><div class="gs_gray">Toxicology letters 292, 63-72<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16485258059507678588" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 9,956,296<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5143838117778963496" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 9,937,267<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8593439100003848685" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Tumor-selective bioactivation of duocarmycin bioprecursors by cytochrome P450 enzymes provides an opportunity to treat drug-resistant breast cancer cells</a><div class="gs_gray">SD Shnyder, PM Loadman, M Sutherland, HM Sheldrake, M Searcey, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 4541-4541<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14216640732254565072" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Design and synthesis of membrane type matrix metalloproteinase (MT-MMP) targeted anti-tumor agents.</a><div class="gs_gray">RA Falconer, AM Youssef, JG Warren, GR Morais, A Mitchell, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 5669-5669<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15181953200396818448" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Chromatographic analysis of polysialic acid released from neural adhesion molecule presented on glioma cell membranes</a><div class="gs_gray">N Al-Hasawi, M Volapato, P Loadman</div><div class="gs_gray">KUWAIT JOURNAL OF SCIENCE &amp; ENGINEERING 38 (2 A), 107-130<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9630092249509530041" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">427 The development and evaluation of an experimental model for assessing convective fluid flow through multicell layers</a><div class="gs_gray">R Phillips, H Makeen, N Periasamy, P Loadman, S Smye, B Sleeman, ...</div><div class="gs_gray">Ejc Supplements 7 (8), 135-136<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9741788276293586379" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Development of tumour-selective and endoprotease-activated anticancer therapeutics</a><div class="gs_gray">JH Gill, PM Loadman</div><div class="gs_gray">The Cancer Degradome, 853-876<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2874377400017577465" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Design, synthesis, biophysical and biological evaluation of a series of methyl ester-terminated pyrrolobenzodiazepine (PBD)-poly (N-methylpyrrole) conjugates.</a><div class="gs_gray">G Wells, PW Howard, C Martin, ZA Sands, CA Laughton, A Tiberghien, ...</div><div class="gs_gray">Clinical Cancer Research 11 (24), 9015S-9015S<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17259697065955462882" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Phase I/II clinical evaluation of intravesical EOquin (EO9) against superficial bladder cancer</a><div class="gs_gray">RM Phillips, PM Loadman, SW Martin, S Basu, V Palit, S Tariq, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 940-940<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2981379552108444834" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Pharmacokinetic studies of ThioTEPA in patients and mice and effect of co-administration of nandrolone decanoate</a><div class="gs_gray">BJ McDermott, JA Double, MC Bibby, P Loadman, RL Turner</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 52 (3), 458-458<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7021312519422237735" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4</a><div class="gs_gray">A Charalambous, V Mico, LE McVeigh, G Marston, N Ingram, M Volpato, ...</div><div class="gs_gray">Nanomedicine: Nanotechnology, Biology and Medicine 36, 102401<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1536706930515207895" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid</a><div class="gs_gray">M Volpato, N Ingram, SL Perry, J Spencer, AD Race, C Marshall, ...</div><div class="gs_gray">Cancer chemotherapy and pharmacology 87 (2), 173-184<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18203812350753658305" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitors</a><div class="gs_gray">X Guo, JR Malcolm, MM Ali, GR Morais, SD Shnyder, PM Loadman, ...</div><div class="gs_gray">Analyst 145 (13), 4512-4521<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11769895624533697759" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Investigating the mechanisms of cellular uptake and metabolism of ICT2588, an MT-MMP-activated prodrug</a><div class="gs_gray">FM Barnieh, AD Race, SD Shnyder, PM Loadman, RA Falconer</div><div class="gs_gray">Cancer Research 79 (13 Supplement), 350-350<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18066770276529137505" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Intracellular pharmacokinetics of 5FU and palbociclib: Uptake and efflux in disaggregated cells and 3D models</a><div class="gs_gray">M Jove, P Loadman, J Spencer, L Sulayman, J Wicks, A Race, C Twelves</div><div class="gs_gray">Cancer Research 77 (13 Supplement), 4205-4205<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1666193114035339364" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Polysialyltransferase ST8SiaII as a target for neuroblastoma dissemination</a><div class="gs_gray">SM Elkashef, RF Saeed, GR Morais, X Guo, M Sini, VF Viprey, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 1270-1270<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2989307915602916335" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Improved delivery of paclitaxel to prostate tumors: a membrane-type matrix metalloproteinase (MT-MMP)-targeted approach</a><div class="gs_gray">PM Loadman, J Giménez-Warren, A Mitchell, AD Race, JA Spencer, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 2054-2054<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17202855426846425978" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:EkHepimYqZsC" class="gsc_a_at">Polysialyltransferase ST8SiaII: A novel target for the treatment of neuroblastoma</a><div class="gs_gray">SM Elkashef, V Viprey, RF Saeed, BR Springett, M Sutherland, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 5431-5431<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16150289433929479683" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Compounds</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent App. 14/553,803<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16137505519185601188" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Distribution of anti-cancer drugs in solid tumours studied by MALDI-MSI</a><div class="gs_gray">A Batubara</div><div class="gs_gray">PQDT-Global<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17015671845691006926" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Polysialyltransferase ST8SiaII: a new target for the treatment of metastatic tumors</a><div class="gs_gray">V Viprey, BR Springett, Y Al-Saraireh, M Northrop, M Sutherland, R Saeed, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 1774-1774<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6819460535615996510" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Phase I study of the DNA minor groove binding pyrrolobenzodiazepine dimer (SJG 136) administered every 21 days in patients with advanced solid tumours</a><div class="gs_gray">D Hochhauser, T Meyer, P Loadman, VJ Spanswick, M Cobb, RH Begent, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 2566-2566<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1316063442276689453" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">The use of pharmacokinetic and pharmacodynamic endpoints to determine dose of AQ4N given with radiotherapy (RT)</a><div class="gs_gray">A Benghiat, WP Steward, M Middleton, D Talbot, LH Patterson, SJ Ford, ...</div><div class="gs_gray">Journal of Clinical Oncology 23 (16_suppl), 2062-2062<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13315201053238342089" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Tumour targeting prodrugs activated by metallo matrixproteinases</a><div class="gs_gray">D Mincher, A Turnbull, M Bibby, P Loadman</div><div class="gs_gray">US Patent App. 10/469,956<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1163848310022023734" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Intravesical EOquin (EO9): a new treatment for superficial bladder cancer–results of phase I study</a><div class="gs_gray">V Palit, R Puri, T Shah, G FLANNIGAN, P LOADMAN, R PHILLIPS</div><div class="gs_gray">Bju International-Supplement 93, 89-90<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=67310137278127661" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Does NQO1 [NAD (P) H quinone oxidoreductase] genotype influence the response to mitomycin C in superficial bladder tumours?</a><div class="gs_gray">S Basu, SW Martin, JE Brown, PM Loadman, GM Flannigan, T Shah, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S32-S32<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15316268506141045612" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Bioavailability of novel anticancer chalcones in nude mice bearing xenografts</a><div class="gs_gray">P Gibson, PM Loadman, SD Shnyder, PA Cooper, MC Bibby, G Potter, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S27-S27<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1893222681208381147" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Intracellular and in vivo distribution of the pyrrolobenzodiazepine dimer SJG-136, a novel sequence-selective DNA minor groove cross-linking agent</a><div class="gs_gray">GP Wilkinson, PM Loadman, JP Taylor, TC Jenkins, JA Double, ...</div><div class="gs_gray">European Journal of Cancer 38, S28-S29<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12228584597052315757" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:dshw04ExmUIC" class="gsc_a_at">Anticancer drug development</a><div class="gs_gray">P Loadman</div><div class="gs_gray">British journal of cancer 86 (10), 1665-1666<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7038644871466577167" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Predicting the response of human tumour xenografts to mitomycin C on the basis of tumour enzymology and metabolism.</a><div class="gs_gray">RM Phillips, PM Loadman, CM Jarrett, BM Burger, DJ Swaine, HH Fiebig</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 48-48<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12940996953180569664" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Pre-clinical evaluation of a novel chloroethylating agent, Clomesone</a><div class="gs_gray">AM Matthew, RM Phillips, PM Loadman, MC Bibby</div><div class="gs_gray">British journal of cancer 67 (3), 441-446<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14692301448660219977" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:PaBasH6fAo0C" class="gsc_a_at">The Relationship Between the</a><div class="gs_gray">RM Phillips, MC Bibby, JA Double, PM Loadman</div><div class="gs_gray">Vitro<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18180217085125567559" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ldfaerwXgEUC" class="gsc_a_at">INITIAL PLASMA DISPOSITION STUDIES OF MOLECULAR COMBINATIONS OF 5-FLUOROURACIL AND NITROSOUREAS IN MICE</a><div class="gs_gray">PM Loadman, MC Bibby, JA Double, RS McElhinney</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 62 (3), 515-515<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9124560658403781675" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">IMPROVED EXPERIMENTAL ANTI-TUMOR ACTIVITY OF ADRIAMYCIN BY SPLIT DOSE SCHEDULING</a><div class="gs_gray">NR Sleigh, PM Loadman, MC Bibby, JA Double</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 58 (2), 238-238<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15068979439526200648" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:M05iB0D1s5AC" class="gsc_a_at">RELATIONSHIP BETWEEN PHARMACOKINETICS AND STABILITY OF TCNU AND INVITRO SENSITIVITY OF MOUSE COLON-TUMOR CELLS</a><div class="gs_gray">RM Phillips, PM Loadman, MC Bibby, JA Double</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (2), 199-200<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9890176335952278957" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Methods of assessment of polysialyltransferase inhibitors for treatment of tumor cell dissemination</a><div class="gs_gray">X Guo, JR Malcolm, A Patel, MM Ali, GR Morais, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 81 (13 Supplement), 2872-2872<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds</a><div class="gs_gray">N Ortuzar, K Karu, D Presa, GR Morais, HM Sheldrake, SD Shnyder, ...</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry 40, 116167<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid</a><div class="gs_gray">M Volpato, N Ingram, SL Perry, J Spencer, AD Race, C Marshall, ...</div><div class="gs_gray">Cancer Chemotherapy and Pharmacology 87 (6), 879-880<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary Ileostomy</a><div class="gs_gray">G Nana, S Mitra, H Watson, C Young, HM Wood, SL Perry, AD Race, ...</div><div class="gs_gray">The Journal of nutrition<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:43bX7VzcjpAC" class="gsc_a_at">An assay for quantitative analysis of polysialic acid expression in cancer cells</a><div class="gs_gray">X Guo, SM Elkashef, A Patel, GR Morais, SD Shnyder, PM Loadman, ...</div><div class="gs_gray">Carbohydrate Polymers 259, 117741<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Immunomodulatory effects of PI3Kδ inhibition in solid tumors–evaluation in a randomized phase II trial</a><div class="gs_gray">C Ottensmeier, S Eschweiler, CR Suastegui, E King, L Chudley, J Thomas, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">R Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 10,912,839<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:48xauSegjOkC" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent App. 16/946,391<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Optimizing the combination of the CDK4/6 inhibitor palbociclib and paclitaxel using cell cycle analysis</a><div class="gs_gray">JA Spencer, AD Race, PA Cooper, SD Shnyder, PM Loadman, ...</div><div class="gs_gray">Cancer Research 80 (16 Supplement), 4847-4847<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:bKqednn6t2AC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 10,556,014<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">An efficient cell-based assay for quantification of cellular polysialic acid in neuroblastoma</a><div class="gs_gray">X Guo, FM Barnieh, J Malcolm, AD Race, GR Morais, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 79 (13 Supplement), 241-241<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:1taIhTC69MYC" class="gsc_a_at">MMP-ACTIVATED VASCULAR DESTRUCTIVE AGENTS</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Mmp aktyvinti kraujagysles ardantys agentai</a><div class="gs_gray">R Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Mmp-sensitive taxane prodrug</a><div class="gs_gray">P Loadman, R Falconer, J Gill</div><div class="gs_gray">US Patent App. 16/065,517<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Mmp activated vascular disrupting agents</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Specifinė mmp-14 skaldymo seka</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Synthesis and biologic evaluation of diethylbenzaldehyde analogues to probe functional activity of aldehyde dehydrogenase activity in cancer</a><div class="gs_gray">A Ibrahim, M Sadiq, D Presa, I Ntafoulis, A Alkawi, F Frame, NJ Maitland, ...</div><div class="gs_gray">Cancer Research 78 (13 Supplement), 1662-1662<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Abstract LB-004: A novel theranostic strategy for MMP-14 expressing glioblastomas impacts survival</a><div class="gs_gray">Z Chen, K Li, G Morais, J Klockow, K Yerneni, L Pisani, F Chin, S Mitra, ...</div><div class="gs_gray">Cancer Research 78 (13 Supplement), LB-004-LB-004<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Preclinical intratumoral pharmacokinetics (PK) of capecitabine (Cap) given+/-eribulin (Eri)</a><div class="gs_gray">MJ Casulleras, J Spencer, P Loadman, M Clench, S Shnyder, P Cooper, ...</div><div class="gs_gray">Cancer Research 78 (13 Supplement), 4926-4926<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:IRz6iEL74y4C" class="gsc_a_at">OTU-023 Randomised trial of EPA and aspirin for colorectal cancer chemoprevention: the seafood polyp prevention trial</a><div class="gs_gray">M Hull, K Sprange, T Hepburn, W Tan, A Shafyat, G Clifford, C Rees, ...</div><div class="gs_gray">Gut 67 (Suppl 1), A183-A183<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Expression of membrane-type matrix metalloproteinases (MT-MMPS) in head and neck squamous cell carcinomas, a target for prodrug development</a><div class="gs_gray">R Ankrah, SD Shnyder, JA McCaul, PA Batman, R Falconer, PM Loadman</div><div class="gs_gray">Cancer Research 77 (13 Supplement), 969-969<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Mechanistic interrogation of pre-treatment low dose aspirin effects in HER 2 positive breast cancer</a><div class="gs_gray">IS Miller, S Khan, LP Shiels, S Das, B Moran, FP Leacy, PM Loadman, ...</div><div class="gs_gray">Cancer Research 77 (13 Supplement), 1254-1254<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">A liquid chromatography–tandem mass spectrometry method to measure fatty acids in biological samples B Analytical technologies in the biomedical and life sciences</a><div class="gs_gray">M Volpato, JA Spencer, AD Race, A Munarini, A Belluzzi, AJ Cockbain, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tuHXwOkdijsC" class="gsc_a_at">5-Fluorouracil (5FU) intratumoural pharmacokinetics: Rapid uptake in cells and in spheroids (SPH)</a><div class="gs_gray">M Jove, P Loadman, J Wicks, J Spencer, A Race, R Salazar, CJ Twelves</div><div class="gs_gray">Annals of Oncology 27, vi543<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:wKETBy42zhYC" class="gsc_a_at">VESSEL DESTROYERS ACTIVATED BY MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Probing cytochrome P450 activity with benzofuran-based duocarmycins in a panel of head and neck cancer cell lines and CYP1A1, 1B1 and CYP2W1 transfected cell lines</a><div class="gs_gray">D Presa, PM Loadman, G Nigro, HM Sheldrake, M Sutherland, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 3105-3105<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:FiytvqdAVhgC" class="gsc_a_at">MMP-ACTIVATED vascular damaging FUNDS</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Agentes de interrupción vascular activados por MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:7H_MAutzIkAC" class="gsc_a_at">MMP-activated vascular damaging agents</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:WC23djZS0W4C" class="gsc_a_at">Agentes disruptores vasculares activados por MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">ToTem: A phase Ib trial of temisirolimus with gemcitabine and cisplatin.</a><div class="gs_gray">S Pacey, RJ Jones, AC Young, A Protheroe, AJ Birtle, J Garcia Corbacho, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), e16032-e16032<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Analysis of HSP10 as a putative biomarker of breast cancer</a><div class="gs_gray">S Shaheed, A Hadjisavvas, K Sokratous, P Loadman, C Sutton, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 1576-1576<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Practical aspects of pharmacokinetics and pharmacodynamics</a><div class="gs_gray">PM Loadman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">CYP2W1 as a novel therapeutic target in colon cancer</a><div class="gs_gray">K Pors, PM Loadman, S Travica, SD Shnyder, M Sutherland, H Sheldrake, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 1779-1779<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:hkOj_22Ku90C" class="gsc_a_at">MT-MMP cleavage profiling using rapid endopeptidase profiling library (REPLi)</a><div class="gs_gray">A Mitchell, J Giménez-Warren, SD Shnyder, JH Gill, RA Falconer, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 5391-5391<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:evX43VCCuoAC" class="gsc_a_at">OC. 10.1 EICOSAPENTAENOIC ACID-FREE FATTY ACID PREVENTS AND SUPPRESSES COLONIC TUMOURS IN COLITIS-ASSOCIATED COLORECTAL CANCER</a><div class="gs_gray">G Piazzi, G D'Argenio, A Prossomariti, V Lembo, G Mazzone, M Candela, ...</div><div class="gs_gray">Digestive and Liver Disease, S24<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">289 Progress in drugging CYP1A1, 1B1 and CYP2W1 overexpressed in cancer</a><div class="gs_gray">K Pors, V Le Morvan, S Travica, SD Shnyder, M Sutherland, ...</div><div class="gs_gray">European Journal of Cancer, 95<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">The effect of eicosapentaenoic acid on growth and vascularity of colorectal liver metastases: results of a phase II randomised doubleblind placebo-controlled trial: Moynihan&nbsp;…</a><div class="gs_gray">A Cockbain, A Belluzzi, P Loadman, G Toogood, M Hull</div><div class="gs_gray">British Journal of Surgery 100<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tYavs44e6CUC" class="gsc_a_at">A randomised controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer&nbsp;…</a><div class="gs_gray">MA Hull, AC Sandell, AA Montgomery, RFA Logan, GM Clifford, CJ Rees, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Inhibition of cell surface polysialic acid biosynthesis modulates tumor cell migration.</a><div class="gs_gray">BR Springett, YMJ Al-Saraireh, V Viprey, M Sutherland, M Begouin, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 4410-4410<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:_B80troHkn4C" class="gsc_a_at">Expression profiling of cofilin-1 in breast cancer cell lines and biopsies.</a><div class="gs_gray">C Sutton, P Loadman, V Speirs, A Hanby, A Hadjisavvas, K Kyriacou</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 2505-2505<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Re-engineering of the duocarmycin structural architecture enables tumour-selective CYP2W1-mediated drug activation in human colon cancer xenografts.</a><div class="gs_gray">K Pors, S Travica, PM Loadman, SD Shnyder, M Sutherland, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 2224-2224<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Deposited in DRO: 12 February 2013 Version of attached file</a><div class="gs_gray">JM Atkinson, CJ Pennington, SW Martin, VA Anikin, AJ Mearns, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Expression of MMP-10 in Human Transitional-Cell Carcinoma of the Bladder</a><div class="gs_gray">JM Seargent, PM Loadman, SW Martin, B Naylor, MC Bibby, JH Gill</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Mark A Hull1, Anna C Sandell2, Alan A Montgomery2, Richard FA Logan3, Gayle M Clifford4, Colin J Rees4</a><div class="gs_gray">PM Loadman, D Whitham</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">224 The Relationship Between the Anti-cancer Activity of the Omega-3 Polyunsaturated Fatty Acid Eicosapentaenoic Acid (EPA) and Colorectal Cancer Cell Migration</a><div class="gs_gray">M Volpato, L Coletta, PM Loadman, MA Hull</div><div class="gs_gray">European Journal of Cancer, 68<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Influence of convective fluid flow on the penetration of anti-cancer drugs through multicell layers</a><div class="gs_gray">RM Phillips, H Makeen, R Periasamy, PM Loadman, PF Jones, ...</div><div class="gs_gray">Cancer Research 71 (8 Supplement), 4455-4455<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Design and development of ICT2700: A proof-of-concept agent demonstrating the therapeutic potential in targeting cytochromes P450 for tumor-selective activation</a><div class="gs_gray">K Pors, SD Shnyder, A Sharma, AC Rigby, MA Grant, M Sutherland, ...</div><div class="gs_gray">Cancer Research 71 (8 Supplement), 3247-3247<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Corrigendum to" A mathematical model of doxorubicin penetration through multicellular layers"[J. Theor. Biol. 257 (2009) 598-608]</a><div class="gs_gray">CJ Evans, RM Phillips, PF Jones, PM Loadman, BD Sleeman, CJ Twelves, ...</div><div class="gs_gray">Journal of Theoretical Biology 273 (1), 235<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Compounds</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tzM49s52ZIMC" class="gsc_a_at">The development and evaluation of a model for assessing convective fluid flow through multicell layers in vitro</a><div class="gs_gray">RM Phillips, PM Loadman, N Periasamy, CJ Twelves, PF Jones, ...</div><div class="gs_gray">Cancer Research 70 (8 Supplement), 5507-5507<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Proteomic investigation of tissues of medical interest by MALDI MSI</a><div class="gs_gray">MC Djidja, MR Clench, PM Loadman, CW Sutton, P Scriven, E Claude, ...</div><div class="gs_gray">Parte: http://hdl. handle. net/10316.2/2632<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Immunohistochemical analysis of NAD (P) H: quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour&nbsp;…</a><div class="gs_gray">RM Phillips, S Basu, JH Gill, PM Loadman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Abstract# 673: Development of a novel class of tumor-selective CYP1A1-activated chloromethylindolines</a><div class="gs_gray">K Pors, H Sheldrake, S Shnyder, M Sutherland, P Loadman, A Gordon, ...</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 673-673<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941</a><div class="gs_gray">R Kristeleit, D Sarker, M Forster, M Lolkema, D Olmos, K Mazina, ...</div><div class="gs_gray">EJC Supplements 2 (7), 121<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:D03iK_w7-QYC" class="gsc_a_at">1202 In silico modelling of Doxorubicin penetration through multicell layers</a><div class="gs_gray">R Phillips, PM Loadman, CJ Evans, PF Jones, SW Smye, BD Sleeman, ...</div><div class="gs_gray">EJC Supplements 2 (7), 121<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:nRpfm8aw39MC" class="gsc_a_at">In silico modelling of doxorubicin penetration through multicell layers</a><div class="gs_gray">R Phillips, P Loadman, P Jones, S Smye, C Twelves, B Sleeman, C Evans</div><div class="gs_gray">EJC SUPPLEMENTS 6 (12), 40-40<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:vRqMK49ujn8C" class="gsc_a_at">CYP1A1 activation and pharmacokinetics of a novel chloromethylpyrrollolindoline with potential as a tumour selective prodrug</a><div class="gs_gray">AD Race, K Pors, SD Shnyder, TC Cooper, HM Sheldrake, M Searcey, ...</div><div class="gs_gray">Ejc Supplements 6 (12), 105-105<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">24 INVITED The evolution of CYPs from metabolising enzymes to potential targets in cancer therapy development</a><div class="gs_gray">LH Patterson, K Pors, PM Loadman, M Sutherland, J Gill, H Sheldrake, ...</div><div class="gs_gray">Ejc Supplements 12 (6), 11<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Analysis of Hepsin mRNA expression by real time PCR and in situ hybridization in normal tissues and tumors of human colon, lung and bladder</a><div class="gs_gray">VS Lim, N Young, B Cronin, S Martin, P Loadman, J Gill, R Phillips</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 1486-1486<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:W5xh706n7nkC" class="gsc_a_at">Membrane Type MMPs Show Differential Expression in Non-Small Cell Lung Cancer (NSCLC) Compared to Normal Lung; Correlation of MMP-14 mRNA Expression and Proteolytic Activity.</a><div class="gs_gray">JM Atkinson, JH Gill, PM Loadman, SW Martin, J Pennington, VA Anikin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in carcinoma in situ of bladder correlates with response to intravesical therapy and disease&nbsp;…</a><div class="gs_gray">J CHERIAN, A VODOVNIK, T SHAH, R PURI, P LOADMAN, R PHILLIPS</div><div class="gs_gray">Bju International 97<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">The serine protease Hepsin demonstrates differential expression and activity in human tumor cells</a><div class="gs_gray">VS Lim, PM Loadman, JH Gill, RM Phillips</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 719-719<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:5ugPr518TE4C" class="gsc_a_at">MATRIX METALLOPROTEINASE-9 EXPRESSION HELPS PREDICT RESPONSE TO INTRAVESICAL THERAPY IN CIS OF BLADDER</a><div class="gs_gray">J Cherian, A Vodovnik, T Shah, R Puri, P Loadman, R Phillips</div><div class="gs_gray">European Urology Supplements 2 (5), 75<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">312 POSTER Preclinical evaluation of a rationally designed novel class of non-hydroxamate Histone Deacetylase inhibitors (HDACi)</a><div class="gs_gray">JH Gill, CWG Fishwick, V Androutsopoulos, A Mohanarajah, T Khamnaen, ...</div><div class="gs_gray">EJC Supplements 12 (4), 98<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:738O_yMBCRsC" class="gsc_a_at">417 POSTER Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) is overexpressed in lung cancer and can cleave peptide-conjugates</a><div class="gs_gray">J Atkinson, R Falconer, C Pennington, S Martin, V Anikin, A Mearns, ...</div><div class="gs_gray">EJC Supplements 12 (4), 128<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Targeting the tumour microenvironment: Design of tissue-specific mechanisms of prodrug activation</a><div class="gs_gray">DJ Mincher, A Turnbull, PM Loadman, E Van Valckenborgh, A Di Salvo, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 17, 34-34<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:UxriW0iASnsC" class="gsc_a_at">Differential cellular localisation and in vitro cytotoxicity of two novel fluorescent pyrrolobenzodiazepine (PBD) conjugate molecules</a><div class="gs_gray">M Suggitt, M Stephenson, G Wells, M Baig, P Loadman, P Howard, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 318-318<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:u_35RYKgDlwC" class="gsc_a_at">The selective activation and release of a therapeutic entity from a novel class of anticancer bioreductive-drug conjugates</a><div class="gs_gray">M Volpato, S Shnyder, R Tanner, M Jaffar, PM Loadman, I Stratford, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 143-143<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Phase 1 dose escalation study of AQ4N, a selective hypoxic cell cytotoxin, with fractionated radiotherapy (RT): First report 2091</a><div class="gs_gray">A Benehiat, W Steward, P Loadman, M Middleton, D Talbot, L Patterson, ...</div><div class="gs_gray">Journal of Clinical Oncology 22<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Inhibition of hypoxia-inducible CA-IX modulates anticancer drug uptake and toxicity</a><div class="gs_gray">CA Parker, M Jaffar, KJ Williams, PM Loadman, RM Phillips, IJ Stratford</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 91, S52-S52<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Selective activation and X-linking ability of a quinone-mustard conjugate (MUP03/704) in vitro: An NQO1-targeted prodrug for cancer therapy</a><div class="gs_gray">M Volpato, PM Loadman, N Abou Zied, M Jaffar, I Stratford, RM Phillips</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 91, S60-S60<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Stromelysin-2 (MMP-10) is overexpressed and enzymatically active in human lung cancers</a><div class="gs_gray">JH Gill, I Kirwan, JM Seargent, SW Martin, S Tijani, VA Anakin, AJ Mearns, ...</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 93-93<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Comparative Preclinical Pharmacokinetic and Metabolic Studies of the Combretastatin Prodrugs Combretastatin A4 Phosphate and A1 Phosphate.</a><div class="gs_gray">PM Loadman, MC Bibby, SD Shnyder, DJ Swaine, IG Kirwan, A Anthoney, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">500 Bioreductive activation and in vitro cytotoxicity of MUP03/704: a novel bioreductive cytotoxic drug conjugate for solid tumours</a><div class="gs_gray">M Volpato, PM Loadman, N Abou Zeid, M Jaffar, IJ Stratford, RM Phillips</div><div class="gs_gray">EJC Supplements 8 (2), 152-153<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Experimental Therapeutics, Preclinical Pharmacology-Comparative Preclinical Pharmacokinetic and Metabolic Studies of the Combretastatin Prodrugs Combretastatin A4 Phosphate and&nbsp;…</a><div class="gs_gray">IG Kirwan, PM Loadman, DJ Swaine, DA Anthoney, GR Pettit, ...</div><div class="gs_gray">Clinical Cancer Research 10 (4), 1446-1453<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:olpn-zPbct0C" class="gsc_a_at">The greater antitumour effect of combretastatin A1 phosphate (CA1P, OXI4503) compared to combretastatin A4 phosphate (CA4P) may be explained by differences in pharmacokinetics&nbsp;…</a><div class="gs_gray">G Kirwan, PM Loadman, DJ Swaine, MC Bibby, GR Pettit, JW Lippert, ...</div><div class="gs_gray">CLINICAL CANCER RESEARCH 9 (16), 6150S-6150S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Design, pharmacokinetics and in vivo metabolism of MMP activated prodrugs.</a><div class="gs_gray">JG Lyle, L Young, A Di Salvo, P Cooper, A Turnbull, MC Bibby, ...</div><div class="gs_gray">CLINICAL CANCER RESEARCH 9 (16), 6180S-6181S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Predicting response to Mitomycin in cancer cell lines and superficial bladder cancer patients.</a><div class="gs_gray">M Volpato, S Basu, J Seargent, J Gill, R Puri, A Scally, P Loadman, ...</div><div class="gs_gray">CLINICAL CANCER RESEARCH 9 (16), 6196S-6197S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Stromelysins are differentially overexpressed in human lung cancers: Potential for therapeutic intervention</a><div class="gs_gray">JM Seargent, PM Loadman, SW Martin, S Tijani, JH Gill</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S64-S64<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Factors influencing human cancer cells response to mitomycin C.</a><div class="gs_gray">M Volpato, PM Loadman, RM Phillips</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S31-S31<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Immunohistochemical analysis of NQO1 and cytochrome P450 reductase in human superficial bladder cancers: Relationship with clinical response to mitomycin C.</a><div class="gs_gray">S Basu, SW Martin, J Seargent, PM Loadman, JH Gill, T Shah, R Puri, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S32-S32<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Pyrrolobenzodiazepine-polyamide libraries: synthesis and DNA binding selectivity. Proceeding of the American Association for Cancer Research</a><div class="gs_gray">G Wells, T Gale, A Hardy, A Hamaguchi, JA Hartley, GP Wilkinson, ...</div><div class="gs_gray">Proceeding of the American Association for Cancer Research 44, 452-<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:f2IySw72cVMC" class="gsc_a_at">Detection of NQO1 polymorphism in archived human bladder tumour tissue using PCR-RFLP: Predicting tumour response to mitomycin C</a><div class="gs_gray">S Basu, RM Phillips, PM Loadman, R Puri, T Shah, GM Flamigan, ...</div><div class="gs_gray">European Urology Supplements 1 (2), 69<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:WZBGuue-350C" class="gsc_a_at">Cytochrome P450 1B1 (CYP1B1) is expressed in human colon adenocarcinomas, but its expression is not limited to the malignant epithelial cells</a><div class="gs_gray">P Gibson, J Gill, MC Bibby, JA Double, J Seargent, PA Khan, P Batman, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 38, S111-S112<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Pharmacokinetics of D709119 (DRH-417), a DNA minor groove-binding pyrrolobenzodiazepine monomer with a novel mechanism of action</a><div class="gs_gray">GP Wilkinson, TC Jenkins, DE Thurston, PW Howard, JA Double, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 38, S28-S28<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">DT Diaphorase and Cytochrome P450 reductase protein localisation in archived bladder tumour specimens: correlation with clinical response following mitomycin therapy</a><div class="gs_gray">S Basu, JE Brown, R Puri, T Shah, GM Flannigan, B Naylor, S Martin, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 38, S21-S21<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:8AbLer7MMksC" class="gsc_a_at">Detection of NQO1 (NAD (P) H: Quinone oxidoreductase, EC 1.6. 99.2) C609T polymorphism in archived human tumour tissue using PCR-RFLP</a><div class="gs_gray">RM Phillips, S Basu, PM Loadman, R Puri, GM Flannigan, T Shah, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 38, S21-S21<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:abG-DnoFyZgC" class="gsc_a_at">In vivo antitumour activity and pharmacokinetics of NU: UB 31 a anthraquinone-petide conjugate</a><div class="gs_gray">S Jackson, JA Double, PM Loadman, DJ Mincher, A Turnbull, MC Bibby</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 86, S112-S112<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Anal. Proc. Anal. Proc. 30, 51, 1993</a><div class="gs_gray">PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:GtLg2Ama23sC" class="gsc_a_at">J. Konopa, J. Med. Chem. J. Konopa, J. Med. Chem. 33, 49, 1990</a><div class="gs_gray">PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Drug Intell. Clin. Pharmacy Drug Intell. Clin. Pharmacy 20, 97, 1986</a><div class="gs_gray">PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Adv. Cancer Chemother. Adv. Cancer Chemother. 10, 3-13, 1985</a><div class="gs_gray">PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:YohjEiUPhakC" class="gsc_a_at">J. Chromatogr. Biomed. Appl. J. Chromatogr. Biomed. Appl. 422, 175, 1987</a><div class="gs_gray">CL CHEN, KK THOEN, FM UCKUN, PM LOADMAN, CR CALABRESE</div><div class="gs_gray">Journal of chromatography. B, Biomedical sciences and applications 764 (1&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Matrix metalloproteinase 9 expression in prostate tumour and stromal cells</a><div class="gs_gray">MJ Thompson, J Crimmins, S Ganta, PM Loadman</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 87-87<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Poster Sessions Wednesday 20 November $21</a><div class="gs_gray">RM Phillips, S Basu, PM Loadman, R Puri, GM Flannigan</div><div class="gs_gray">Cancer Res 7, 1313<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Predicting tumour responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumour homogenates.</a><div class="gs_gray">RM Phillips, AM Burger, PM Loadman, CM Jarrett, DJ Swaine, HH Fiebig</div><div class="gs_gray">CLINICAL CANCER RESEARCH 6, 4527S-4527S<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Synthesis and anti-cancer activity of DT-diaphorase activated naphthoquinone pro-drugs and comparison with EO9</a><div class="gs_gray">G Steans, PM Loadman, DJ Maitland, RM Phillips</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 83, 70-70<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Factors influencing the pharmacodynamics of the HPMA doxorubicin copolymer, PK1</a><div class="gs_gray">R Mikaty, PM Loadman</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 83, 68-68<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Regular Articles-Experimental Therapeutics-Predicting Tumor Responses to Mitomycin C on the Basis of DT-Diaphorase Activity or Drug Metabolism by Tumor Homogenates&nbsp;…</a><div class="gs_gray">RM Phillips, AM Burger, PM Loadman, CM Jarrett, DJ Swaine, HH Fiebig</div><div class="gs_gray">Cancer Research 60 (22), 6384-6390<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Preclinical activity and pharmacology of RH1 (2, 5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1, 4-benzoquinone)</a><div class="gs_gray">PM Loadman, LSE Lim, MC Bibby</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 80, 92-92<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Analytical sciences: the international journal of the Japan Society for Analytical Chemistry 19 (1), 3-14, 2003-01-10</a><div class="gs_gray">N Mano, S Iijima, K Kasuga, J GOTO</div><div class="gs_gray">Biochemistry 38, 14396<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Experimental Therapeutics, Preclinical Pharmacology-Pharmacokinetics of PK1 and Doxorubicin in Experimental Colon Tumor Models with Differing Responses to PK1</a><div class="gs_gray">PM Loadman, MC Bibby, JA Double, WM Al-Shakhaa, R Duncan</div><div class="gs_gray">Clinical Cancer Research 5 (11), 3682-3688<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Peptide Res. Peptide Res. 7, 265, 1994</a><div class="gs_gray">AJ MOORE, PM LOADMAN, DA DEVINE, MC BIBBY</div><div class="gs_gray">Journal of chromatography. B, Biomedical applications 672 (2), 225-231<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Pre-clinical Evaluation of the Activity and Pharmacokinetics of Molecular Combinations of 5-Fluorouracil and Nitrosoureas</a><div class="gs_gray">PM Loadman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">PLASMA PHARMACOKINETIC STUDIES ON B. 3970, A MOLECULAR COMBINATION OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA (CNU), IN A MURINE MODEL</a><div class="gs_gray">PM LOADMAN, MC BIBBY, AM MATTHEW</div><div class="gs_gray">BRITISH JOURNAL OF PHARMACOLOGY 110, P169-P169<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">METABOLISM AND PHARMACOKINETICS OF THE NITROSOUREA B-3996</a><div class="gs_gray">PM LOADMAN, PB HULBERT, MC BIBBY</div><div class="gs_gray">BRITISH JOURNAL OF PHARMACOLOGY 110, P168-P168<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:08ZZubdj9fEC" class="gsc_a_at">EFFECT OF TWEEN80 ON THE DISPOSITION OF THIOTEPA GIVEN INTRAVESICALLY</a><div class="gs_gray">BJ MCDERMOTT, JRW MASTERS, PJR SHAH, E FENWICK, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 58 (2), 248-249<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:tOudhMTPpwUC" class="gsc_a_at">ANTITUMOR-ACTIVITY AND PHARMACOKINETICS OF LM985 AND LM975 IN MICE BEARING TRANSPLANTABLE COLON TUMORS</a><div class="gs_gray">JA DOUBLE, MC BIBBY, RM PHILLIPS, PM LOADMAN</div><div class="gs_gray">INVESTIGATIONAL NEW DRUGS 5 (1), 84-84<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:sSrBHYA8nusC" class="gsc_a_at">ANTITUMOR-ACTIVITY AND PHARMACOKINETICS OF LM985 IN MOUSE COLON TUMORS</a><div class="gs_gray">JA DOUBLE, MC BIBBY, PM LOADMAN</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 54 (1), 153-153<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">METHODOLOGY FOR ASSAY OF THIOTEPA IN PLASMA AND INITIAL PHARMACOKINETIC STUDIES</a><div class="gs_gray">BJ MCDERMOTT, JA DOUBLE, MC BIBBY, DEV WILMAN, P LOADMAN, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 50 (2), 261-261<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Theranostic nanoparticles enhance the response of glioblastomas to radiation. Nanotheranostics 2019; 3 (4): 299-310. doi: 10.7150/ntno. 35342</a><div class="gs_gray">W Wu, JL Klockow, S Mohanty, KS Ku, M Aghighi, S Melemenidis, Z Chen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:Ehil0879vHcC" class="gsc_a_at">Antitumor Activity of a Duocarmycin Analogue Rationalized to Be</a><div class="gs_gray">M Sutherland, JH Gill, PM Loadman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:nZcligLrVowC" class="gsc_a_at">CONCISE ARTICLE</a><div class="gs_gray">V Vinader, M Sadiq, M Sutherland, M Huang, PM Loadman, L Elsalem, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Mathematical Model of Doxorubicin Transport within Solid Tumours</a><div class="gs_gray">CM Groh, BD Sleeman, ME Hubbard, PF Jones, PM Loadman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Development of Tumour-Selective and Endoprotease-Activated Anticancer</a><div class="gs_gray">JH Gill, PM Loadman</div><div class="gs_gray">The Cancer Degradome, 853<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7MtgsawAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7MtgsawAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Targeting of Hypoxia-related Proteins in AQ4N treated solid Tumour Xenografts by MALDI-Ion Mobility Separation-Mass Spectrometry Imaging</a><div class="gs_gray">MC Djidja, E Claude, PM Loadman, CW Sutton, V Carolan, MR Clench</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–289</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>